Hormone Replacement Therapy Market: Factors Affecting Growth and Future Forecast | CAGR 5.1%
Hormone Replacement Therapy Market– Global Outlook and Forecast 2023-2030 is latest research study released by Allied Market Research evaluating the market risk side analysis, highlighting opportunities and leveraged with strategic and tactical decision-making support (2023-2030). The market Study is segmented by key a region that is accelerating the marketization. The report provides information on market research and development, growth drivers, and the changing investment structure of the Global Hormone Replacement Therapy Market. Some of the key players profiled in the study are Abbott Laboratories, Bayer, Eli Lilly and Company, F. Hoffmann-La Roche (Genentech), Hisamitsu Pharmaceutical (Noven Pharmaceuticals), Merck, Mylan (Viatris), Novartis International, Novo Nordisk A/S, and Pfizer. The global Hormone Replacement Therapy market is projected to reach $46.5 billion by 2027, registering a CAGR of 5.1% from 2020 to 2027.
Click To get FREE SAMPLE PDF (Including Full TOC, Table & Figures): https://www.alliedmarketresearch.com/request-sample/9873
Hormone Replacement Therapy Market Outlook 2020-2030
The global hormone replacement therapy market is divided into several therapy types, including estrogen hormone replacement therapy, human growth hormone replacement therapy, thyroid hormone replacement therapy, testosterone hormone replacement therapy, and progestogen hormone replacement therapy. In 2019, the estrogen hormone replacement therapy segment dominated the market due to its frequent use in women who have undergone menopause or hysterectomy to regulate hormonal balance. In contrast, the human growth hormone replacement therapy segment is expected to grow at the fastest rate due to the increased incidence of growth hormone deficiency (GHD) or dwarfism, particularly among infants. According to the WHO, approximately 15 million premature infants are born annually, and about 85% of them are not fully developed.
Based on the route of administration, the market is classified into oral, parenteral, and other methods. The oral segment held the largest market share in 2019 and is expected to grow rapidly during the forecast period. This is due to the increased preference for oral hormone replacement therapy products and the associated convenience of use. Furthermore, this route of administration reduces the need for patients to visit clinics for treatment, resulting in decreased healthcare costs.
Regarding indication, the market is categorized into menopause, hypothyroidism, male hypogonadism, growth hormone deficiency, and others. In 2019, the menopause segment dominated the market due to the growing population of postmenopausal women and the expansion of the menopausal window from 40 to 55 years. For example, the National Menopause Foundation reports that in the United States, approximately 1.3 million women become menopausal each year between the ages of 51 and 52. As a result, the global population of menopausal and postmenopausal women is projected to reach 1.2 billion by 2030.
Marketing Communication and Sales Channel
Understanding “marketing effectiveness” on a continual basis, help determine the potential of advertising and marketing communications and allow to use of best practices to utilize untapped audience. In order to make marketers make effective strategies and identify why the target market is not giving attention, we ensure the Study is Segmented with appropriate marketing & sales channels to identify potential market size by value & Volume* (if Applicable).
Have Any Query? Ask Our Expert @: https://www.alliedmarketresearch.com/purchase-enquiry/9873
The segments and sub-section of Hormone Replacement Therapy market is shown below:
By Therapy Type: Estrogen Hormone Replacement Therapy, Human Growth Hormone Replacement Therapy, Thyroid Hormone Replacement Therapy, Testosterone Hormone Replacement Therapy, and Progestogen Hormone Replacement Therapy
By Route of Administration: Oral, Parenteral, and Others
By Indication: Menopause, Hypothyroidism, Male Hypogonadism, Growth Hormone Deficiency, and Others
Some of the key players involved in the Market are: Abbott Laboratories, Bayer, Eli Lilly and Company, F. Hoffmann-La Roche (Genentech), Hisamitsu Pharmaceutical (Noven Pharmaceuticals), Merck, Mylan (Viatris), Novartis International, Novo Nordisk A/S, and Pfizer.
Important years considered in the Hormone Replacement Therapy study:
Historical year – 2017-2021; Base year – 2021; Forecast period** – 2022 to 2030 [** unless otherwise stated]
If opting for the Global version of Hormone Replacement Therapy Market; then below country analysis would be included:
– North America (USA, Canada and Mexico)
– Europe (Germany, France, the United Kingdom, Netherlands, Italy, Nordic Nations, Spain, Switzerland and Rest of Europe)
– Asia-Pacific (China, Japan, Australia, New Zealand, South Korea, India, Southeast Asia and Rest of APAC)
– South America (Brazil, Argentina, Chile, Colombia, Rest of countries etc.)
– Middle East and Africa (Saudi Arabia, United Arab Emirates, Israel, Egypt, Turkey, Nigeria, South Africa, Rest of MEA)
Introduction about Hormone Replacement Therapy Market
Hormone Replacement Therapy Market Size (Sales) Market Share by Type (Product Category)
Hormone Replacement Therapy Market by Application/End Users
Hormone Replacement Therapy Sales (Volume) and Market Share Comparison by Applications
Global Hormone Replacement Therapy Sales and Growth Rate (2020-2030)
Hormone Replacement Therapy Competition by Players/Suppliers, Region, Type, and Application
Hormone Replacement Therapy (Volume, Value, and Sales Price) table defined for each geographic region defined.
Hormone Replacement Therapy Players/Suppliers Profiles and Sales Data
Key Raw Materials Analysis & Price Trends
Supply Chain, Sourcing Strategy and Downstream Buyers, Industrial Chain Analysis
……..and view more in complete table of Contents
Procure Complete Report (220+ Pages PDF with Insights, Charts, Tables, and Figures) @ https://www.alliedmarketresearch.com/checkout-final/9796b8bd3fde2ca5f96e4d2ab9575232
Thanks for reading this article; you can also get an individual chapter-wise sections or region-wise report versions like North America, LATAM, Europe, or Southeast Asia.
Read More Trending Reports Here:
Computed Tomography (CT) Market by Type (Low Slice, Medium Slice, and High Slice), Application (Oncology, Neurology, Cardiovascular, Musculoskeletal, and Others), and End User (Hospitals & Clinic, Diagnostic Centers, and Others): Global Opportunity Analysis and Industry Forecast, 2021-2030
Dermatological Drugs Market by Disease (Acne, Dermatitis, Psoriasis, Skin Cancer, Rosacea, Alopecia, and Others), Type (Prescription-based Drugs, and Over-the-Counter Drugs), and Route of Administration (Topical Administration, Oral Administration, and Parenteral Administration): Global Opportunity Analysis and Industry Forecast, 2021-2030
Antiviral Therapies Market by Type (Generic Drugs and Branded Drugs), Application (HIV, Hepatitis, Herpes Virus, Influenza, and Other Applications), and Mechanism of Action (Nucleotide Polymerase Inhibitor, Reverse Transcriptase Inhibitors, Protease Inhibitors, and Others): Global Opportunity Analysis and Industry Forecast, 2019-2026
About Us:
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
Contact Us:
David Correa
Portland, OR, United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022,
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
Editor Details
-
Company:
- The Wire Times
